Cost-effectiveness of neuromuscular ultrasound in focal neuropathies.

ABSTRACT:

Objective

To evaluate the cost-effectiveness of neuromuscular ultrasound (NMUS) for the evaluation of focal neuropathies.

Methods

A prior prospective, randomized, double-blind controlled trial demonstrated that NMUS, when added to electrodiagnostic testing, resulted in improved clinical outcomes after 6 months of follow-up. From this study, we abstracted quality-adjusted life-years (QALYs) from the 36-item Short Form Health Survey and entered this health-utility estimate into a mixed trial and model-based cost-effectiveness analysis from the societal perspective. Costs of intervention (NMUS) were estimated from Medicare payment rates for Current Procedural Terminology codes. Health care use was otherwise estimated to be equal, but sensitivity analyses further examined this a

SUBMITTER: Mandeville R 

PROVIDER: S-EPMC6556098 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature